Neuroinflammation in Alzheimer's disease:: Potential targets for, disease-modifying drugs

被引：0
|
作者：
Hüll, M [1 ]
Hampel, H [1 ]
机构：
[1] Univ Freiburg, Sch Med, Dept Psychiat, D-79104 Freiburg, Germany
来源：
NEUROINFLAMMATION - FROM BENCH TO BEDSIDE | 2002年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：159 / 178
页数：20
相关论文
共 50 条
  • [21] Alzheimer?s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
    Monteiro, Ana R.
    Barbosa, Daniel J.
    Remiao, Fernando
    Silva, Renata
    [J]. BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [22] A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease
    Ettcheto, Miren
    Busquets, Oriol
    Espinosa-Jimenez, Triana
    Verdaguer, Ester
    Auladell, Carme
    Camins, Antoni
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (12) : 1286 - 1299
  • [23] Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK
    Laurell, Axel A. S.
    Venkataraman, Ashwin V.
    Schmidt, Tatjana
    Montagnese, Marcella
    Mueller, Christoph
    Stewart, Robert
    Lewis, Jonathan
    Mundell, Clare
    Isaacs, Jeremy D.
    Krishnan, Mani S.
    Barber, Robert
    Rittman, Timothy
    Underwood, Benjamin R.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2024, 224 (06) : 198 - 204
  • [24] Potential targets for disease-modifying treatments in MS
    Hartung, HP
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 12 - 16
  • [25] Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease
    Bouvy, Jacoline C.
    Jonsson, Pall
    O'Rourke, Diana
    Chadha, Antonella Santuccione
    Hedberg, Niklas
    Makady, Amr
    Xoxi, Entela
    Gispen-de Wied, Christine
    Schiel, Anja
    Long, Raj
    Gallacher, John
    [J]. CNS DRUGS, 2018, 32 (12) : 1085 - 1090
  • [26] Non-cognitive outcomes in trials of disease-modifying drugs for Alzheimer's disease
    Zekry, D.
    Graf, C. E.
    Giannelli, S. V.
    Gold, G.
    Michel, J. -P.
    [J]. EUROPEAN GERIATRIC MEDICINE, 2012, 3 (01) : 37 - 42
  • [27] Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
    Jacoline C. Bouvy
    Pall Jonsson
    Diana O’Rourke
    Antonella Santuccione Chadha
    Niklas Hedberg
    Amr Makady
    Entela Xoxi
    Christine Gispen-de Wied
    Anja Schiel
    Raj Long
    John Gallacher
    [J]. CNS Drugs, 2018, 32 : 1085 - 1090
  • [28] The search for disease-modifying treatment for Alzheimer's disease
    Aisen, PS
    Davis, KL
    [J]. NEUROLOGY, 1997, 48 (05) : S35 - S41
  • [29] Novel Disease-Modifying Therapies for Alzheimer's Disease
    Jiang, Teng
    Yu, Jin-Tai
    Tan, Lan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 475 - 492
  • [30] Disease-Modifying Alzheimer's Disease Therapeutic Candidate
    Kelleher-Andersson, Judith
    [J]. NEUROTHERAPEUTICS, 2012, 9 (03) : 679 - 680
12345